Bausch Health Companies Inc. Cost of Goods Sold, Amortization (Deprecated 2018-01-31)
Bausch Health Companies Inc. (BHC) reported Cost of Goods Sold, Amortization (Deprecated 2018-01-31) of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSoldAmortization · last filed 2014-02-28
- Bausch Health Companies Inc. cost of goods sold, amortization (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $0.00.
- Bausch Health Companies Inc. cost of goods sold, amortization (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $0.00.
- Bausch Health Companies Inc. cost of goods sold, amortization (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. cost of goods sold, amortization (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. cost of goods sold, amortization (deprecated 2018-01-31) for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Bausch Health Companies Inc. cost of goods sold, amortization (deprecated 2018-01-31) for fiscal 2012 was $2.56M, a 68.44% decline from fiscal 2011.
- Bausch Health Companies Inc. cost of goods sold, amortization (deprecated 2018-01-31) for fiscal 2011 was $8.10M, a 0.00% change from fiscal 2010.
- Bausch Health Companies Inc. cost of goods sold, amortization (deprecated 2018-01-31) for fiscal 2010 was $8.10M, a 0.00% change from fiscal 2009.
| Period end | Cost of Goods Sold, Amortization (Deprecated 2018-01-31) 3 month | Cost of Goods Sold, Amortization (Deprecated 2018-01-31) 6 month | Cost of Goods Sold, Amortization (Deprecated 2018-01-31) 9 month | Cost of Goods Sold, Amortization (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $0.00 derived: sum of 3 quarters · filed 2014-02-28 | $0.00 10-K · filed 2014-02-28 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-01 | $0.00 derived: sum of 2 quarters · filed 2013-11-01 | $0.00 10-Q · filed 2013-11-01 | $0.00 derived: sum of 4 quarters · filed 2014-02-28 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-07 | $0.00 10-Q · filed 2013-08-07 | $0.00 derived: sum of 3 quarters · filed 2014-02-28 | $0.00 derived: sum of 4 quarters · filed 2014-02-28 |
| 2013-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $0.00 derived: sum of 3 quarters · filed 2014-02-28 | $531.00K derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $531.00K derived: sum of 3 quarters · filed 2014-02-28 | $2.56M 10-K · filed 2014-02-28 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-01 | $531.00K derived: sum of 2 quarters · filed 2013-11-01 | $2.56M 10-Q · filed 2013-11-01 | $4.58M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $531.00K 10-Q · filed 2013-08-07 | $2.56M 10-Q · filed 2013-08-07 | $4.58M derived: sum of 3 quarters · filed 2014-02-28 | $6.61M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $2.03M 10-Q · filed 2013-05-03 | $4.05M derived: sum of 2 quarters · filed 2014-02-28 | $6.08M derived: sum of 3 quarters · filed 2014-02-28 | $8.10M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $4.05M derived: sum of 2 quarters · filed 2014-02-28 | $6.08M derived: sum of 3 quarters · filed 2014-02-28 | $8.10M 10-K · filed 2014-02-28 |
| 2011-09-30 | $2.03M 10-Q · filed 2012-11-05 | $4.05M derived: sum of 2 quarters · filed 2012-11-05 | $6.08M 10-Q · filed 2012-11-05 | |
| 2011-06-30 | $2.02M 10-Q · filed 2012-08-03 | $4.05M 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | $2.03M 10-Q · filed 2012-05-04 | |||
| 2010-12-31 | $8.10M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $8.10M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |